Glaxosmithkline | L'Utile Operativo



Operating Profit Cambiamento Data
AbbVie USD 5.72B 1.98B 2025-06
Amgen USD 2.66B 1.37B 2025-06
AstraZeneca USD 3.51B 166M 2025-06
Aurora Cannabis CAD -20220000 56.44M 2025-06
Bausch Health Companies USD 457M 181M 2025-06
Bristol-Myers Squibb USD 3.77B 366M 2025-06
Canopy Growth CAD -22080000 1.74M 2025-06
Corcept Therapeutics USD 26.67M 23.26M 2025-06
Drreddys Laboratories INR 16.84B 1.88B 2025-06
Eli Lilly USD 7.02B 1.61B 2025-06
GlaxoSmithKline GBP 2.02B 193M 2025-06
Glaxosmithkline GBP 2.44B 1.74B 2025-06
J&J USD 6.94B 6.69B 2025-06
Merck USD 6.36B 494M 2025-06
Novartis USD 4.86B 201M 2025-06
Pacira USD 10.23M 8.24M 2025-06
Perrigo USD 55.6M 23.8M 2025-06
Pfizer USD 2.6B 1.06B 2025-06
Prestige Brands USD 71.76M 16.67M 2025-06
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 1.71B 573M 2025-06
Supernus Pharmaceuticals USD 12.14M 14.74M 2025-06
Takeda JPY 184.56B 259.5B 2025-06
Teva Pharmaceutical Industries USD 899M 380M 2025-06
Zoetis USD 1.02B 205M 2025-06


Glaxosmithkline L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Sep 2025.